This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Allscripts Announces Strategic Acquisitions Of DbMotion And Jardogs

dbMotionAllscripts' acquisition is a natural evolution of a strategic partnership that began in 2009 and was strengthened in 2011 when Allscripts made an equity investment in the company.  Since then, Allscripts has become the largest integrator of dbMotion technology, a key component of the Allscripts Connected Community of Health . Today, 370 hospitals and 2,800 clinics use dbMotion technology globally. 

"We share Allscripts' vision to create an open, EHR-neutral, connected community of health," said Yuval Ofek, Chairman and Chief Executive Officer, dbMotion.  "We look forward to accelerating our mission to impact industry-wide interoperability and to deliver solutions that support new value-based payment models and improve the health of populations." 

Allscripts acquired dbMotion for approximately $235 million in total consideration.  This consists of $145 million in cash, $50 million of Allscripts common stock and $40 million in cash via a note payable, due within 18 months.  Allscripts will fund the transaction with existing cash and borrowings under its revolving credit facility.

JardogsJardogs offers cloud-based patient and consumer engagement technology that enables communication and collaboration between physicians, caregivers, and medical consumers. 

"Improved alignment between FollowMyHealth™ and the Allscripts platforms will benefit clients and patients," said Jim Hewitt, Chief Executive Officer.  "We're very excited about connecting patients to their physicians and communities as an integrated extension of Allscripts platform."

Additional benefits resulting from these transactions include control of core strategic platform technologies, improved and consistent client experience as well as the benefit of direct sale economics, including incremental license software margin as well as professional services, hosting and subscription fees.

The Allscripts Board of Directors approved both transactions, unanimously.  On an earnings per share basis, Allscripts expects the transactions to be slightly dilutive in 2013 and accretive in 2014.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs